Last Price
1.00
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Overview
Market Cap
65 Million
Shares Outstanding
65 Million
Avg Volume
383,040
Avg Price (50 Days)
1.47
Avg Price (200 Days)
1.75
PE Ratio
-0.98
EPS
-1.02
Earnings Announcement
19-Mar-2025
Previous Close
0.97
Open
0.97
Day's Range
0.9662 - 1.1548
Year Range
0.83 - 3.79
Trading Volume
1,244,771
Price Change Highlight
1 Day Change
3.09%
5 Day Change
-17.36%
1 Month Change
-36.71%
3 Month Change
-31.51%
6 Month Change
-44.44%
Ytd Change
-35.90%
1 Year Change
-21.26%
3 Year Change
-60.00%
5 Year Change
-90.74%
10 Year Change
-99.95%
Max Change
-99.80%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Discussions
Be the first to like this. Showing 1 of 1 comments
Post a Comment
Latest Videos
Apps
Top Articles
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
actvtrader
I like the 50.00 price target for yahoo!
2014-10-22 15:48